Acurx Pharmaceuticals, Inc. ACXP
1.36
0.00
0.00%
as of 25 Sep
- Market cap
- $7.6M
- P/E
- 0.0×
Follow ACXP
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
Current Ratio |
3.18 | 1.19 | 2.53 | 4.55 | 15.71 | 6.82 | 1.48 | — |
Net Debt/EBITDA |
0.93 | 0.26 | 0.51 | 0.75 | 1.01 | 0.69 | 0.42 | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.85 | 0.74 | 0.67 | 0.62 | 0.39 | 0.73 | 0.67 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (270.80%) | (534.03%) | (243.33%) | (122.61%) | (168.71%) | (261.25%) | (336.86%) | — | |
| (137.98%) | (243.85%) | (170.64%) | (106.87%) | (154.72%) | (159.85%) | (468.62%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(151.21%) | (2,292.44%) | (312.38%) | (165.32%) | (102.72%) | (167.19%) | (723.51%) | — |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | — | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Free Cash Flow per Share |
(4.53) | (12.85) | (15.47) | (13.95) | (11.75) | (10.83) | (16.60) | — |
Cash per Share |
5.04 | 4.59 | 11.80 | 16.85 | 30.36 | 10.26 | 10.34 | — |
Shareholders Equity per Share |
3.52 | 0.76 | 7.37 | 13.53 | 29.08 | 8.73 | 3.41 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
3.52 | 0.76 | 7.37 | 13.53 | 29.08 | 8.73 | 3.41 | — |
Free Cash Flow |
(6.79) | (10.38) | (9.80) | (7.54) | (5.01) | (3.35) | (3.99) | — |
Working Capital |
5.27 | 0.62 | 4.67 | 7.32 | 12.41 | 2.75 | 0.82 | — |
Net Current Asset Value |
5.27 | 0.62 | 4.67 | 7.32 | 12.41 | 2.70 | 0.82 | — |
| Other line items | ||||||||
Quick Ratio |
3.14 | 1.16 | 2.50 | 4.42 | 15.36 | 6.72 | 1.45 | — |
Cash ROIC |
(52.93%) | (240.26%) | (80.73%) | (45.91%) | (19.76%) | (57.03%) | (120.65%) | — |
Accounts Receivable Turnover |
0.00 | 0.00 | — | — | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(4.53) | (12.85) | (15.47) | (13.95) | (11.75) | (10.83) | (16.60) | — |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
0.05 | 0.09 | — | — | — | — | — | — |
Average Payables |
2.83 | 3.14 | 2.55 | 1.45 | 0.65 | 0.86 | 0.86 | — |
Average Assets |
5.77 | 5.78 | 8.54 | 11.32 | 8.24 | 2.88 | 1.27 | — |
Average Common Equity |
2.94 | 2.64 | 5.99 | 9.86 | 7.56 | 1.76 | 1.76 | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Columns are period end dates